The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling

Structure

Volumn 5, Issue 10, 1997, Pages 1361-1372

  Arold, Stefan ^a   Franken, Peet ^a   Strub, Marie Paule ^a   Hoh, Francois ^a   Benichou, Serge ^b   Benarous, Richard ^b   Dumas, Christian ^a  

^a CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Crystal structure; Fyn protein tyrosine kinase; HIV 1; Nef protein; SH3 domain

Indexed keywords

EID: 0031572847     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(97)00286-4     Document Type: Article

References (73)

1. Allan, J.S., et al., & Essex, M. (1985). A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810-813.
2. Trono, D. (1995). HIV accessory proteins: leading roles for the supporting cast. Cell 82, 189-192.
3. Littman, D.R. (1994). Immunodeficiency viruses. Not enough sans Nef. Curr. Biol. 4, 618-620.
4. Cullen, B.R. (1994). The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205, 1-6.
5. Kestler, H.W., et al., & Desrosiers, R.C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
6. Du, Z., et al., & Desrosiers, R.C. (1995). Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674.
7. Baba, T.W., et al., & Ruprecht, R.M. (1995). Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825.
8. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
9. Kirchhoff, F., Greenough, T.C., Brettler, D.B., Sullivan, J.L. & Desrosiers, R.C. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232.
10. Deacon, N.J., et al., & Mills, J. (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
11. Guy, B., et al., & Lecocq, J.P. (1987). HIV F/3• orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269.
12. Pandori, M.W., et al., & Guatelli, J.C. (1996). Producer-cell modification of human immunodeficiency virus type 1 : Nef is a virion protein. J. Virol. 70, 4283-4290.
13. Welker, R., Kottler, H., Kalbitzer, H.R. & Krausslich, H.G. (1996). Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219, 228-236.
14. Schorr, J., et al., & Kalbitzer, H.R. (1996). Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases. J. Virol. 70, 9051-9054.
15. Freund, J., et al., & Kalbitzer, H.R. (1 994). A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 223, 589-593.
16. Aiken, C., Konner, J., Landau, N.R., Lenburg, M.E. & Trono, D. (1994). Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864.
17. Salghetti, S., Mariani, R. & Skowronski, J. (1995). Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Natl. Acad. Sci. USA 92, 349-353.
18. Schwartz, O., et al., & Danos, O. (1995). Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J. Virol. 69, 528-533.
19. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J.M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338-342.
20. Iafrate, A.J., Bronson, S. & Skowronski, J. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16, 673-684.
21. Greenway, A., Azad, A. & McPhee, D. (1995). Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842-1850.
22. Skowronski, J., Parks, D. & Mariani, R. (1 993). Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12, 703-713.
23. Chowers, M.Y., et al., & Guatelli, J.C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914.
24. Miller, M.D., Feinberg, M.B. & Greene, W.C. (1994). The HIV-1 nef gene acts as a positive viral infectivity factor. Trends Microbiol. 2, 294-298.
25. Aiken, C. & Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048-5056.
26. + viruses but not for down-regulation of CD4. EMBO J. 14, 484-491.
27. Chowers, M.Y., Pandori, M.W., Spina, C.A., Richman, D.D. & Guatelli, J.C. (1995). The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212, 451-457.
28. Luo, T. & Garcia, J.V. (1996). The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70, 6493-6496.
29. Sawai, E.T., et al., & Cheng-Mayer, C. (1994). Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 1539-1543.
30. Nunn, M.F. & Marsh, J.W. (1996). Human immunodeficiency virus type 1 Nef associates with a member of the p21 -activated kinase family. J. Virol. 70, 6157-6161.
31. Lee, C.H., et al., & Saksella, K. (1995). A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14, 5006-5015.
32. Collette, Y., et al., & Olive, D. (1996). Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J. Biol. Chem. 271, 6333-6341.
33. Greenway, A., Azad, A., Mills, J. & McPhee, D. (1996). Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70, 6701-6708.
34. Erpel, T. & Courtneidge, S.A. (1995). Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7, 176-182.
35. DeFranco, A.L. (1995). Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr. Opin. Cell Biol. 7, 163-175.
36. Howe, L.R. & Weiss, A. (1995). Multiple kinases mediate T-cell-receptor signaling. Trends Biochem. Sci. 20, 59-64.
37. Li, B., et al., & Kamata, B. (1996). Catalytic activity of the mouse guanine nucleotide exchanger mSOS is activated by Fyn tyrosine kinase and the T-cell antigen receptor in T cells. Proc. Natl. Acad. Sci. USA 93, 1001-1005.
38. Iwashima, M., Irving, B.A., van Oers, N.S., Chan, A.C. & Weiss, A. (1994). Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263, 1136-1139.
39. Tsygankov, A.Y., Broker, B.M., Fargnoli, J., Ledbetter, J.A. & Bolen, J.B. (1992). Activation of tyrosine kinase p60fyn following T cell antigen receptor cross-linking. J. Biol. Chem. 267, 18259-18262.
40. Pawson, T. (1995). Protein modules and signaling networks. Nature 373, 573-580.
41. Lee, C.H., Saksela, K., Mirza, U.A., Chait, B.T. & Kuriyan, J. (1996). Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85, 931-942.
42. Holtzman, D.A., Cook, W.D. & Dunn, A.R. (1987). Isolation and sequence of a cDNA corresponding to a src-related gene expressed in murine hemopoietic cells. Proc. Natl. Acad. Sci. USA 84, 8325-8329.
43. Bolen, J.B., Rowley, R.B., Spana, C. & Tsygankov, A.Y. (1992). The Src family of tyrosine protein kinases in hemopoietic signal transduction. FASEB J. 6, 3403-3409.
44. Freund, J., et al., & Kalbitzer, H.R. (1994). Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 221, 811-819.
45. Grzesiek, S., et al., & Wingfield, P.T. (1996). The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 3, 340-345.
46. Grzesiek, S., et al., & Wingfield, PT. (1997). Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci. 6, 1248-1263.
47. Noble, E.M., Musacchio, A., Saraste, M., Courtneidge, S.A. & Wierenge, R.K. (1993). Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J. 12, 2617-2624.
48. Fujii, Y., et al., & Adachi, A. (1996). Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett. 395, 257-261.
49. Kienzle, N., Freund, J., Kalbitzer, H.R. & Mueller-Lantzsch, N. (1993). Oligomerization of the Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 214, 451-457.
50. Musacchio, A., Saraste, M. & Wilmanns, M. (1994). High resolution crystal structures of tyrosine kinase SH3 domains complexed with proline rich peptides. Nat. Struct. Biol. 1, 546-551.
51. Renzoni, D.A., et al., & Ladbury, J.E. (1996). Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of Pl3-kinase. Biochemistry 35, 15646-15653.
52. Morton, C.J., et al., & Campbell, I.D. (1996). Solution structure and peptide binding of the SH3 domain from human Fyn. Structure 4, 705-714.
53. Wu, X., et al., & Kuriyan, J. (1995). Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226,
54. Weng, Z., et al., & Brugge, J.S. (1995). Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol. Cell Biol. 15, 5627-5634.
55. Shugars, D.C., et al., & Swanstrom, R. (1993). Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 67, 4639-4650.
56. Ratner, L., et al., & Arens, M. (1996). Sequence heterogeneity of Nef transcripts in HIV-1-infected subjects at different stages of disease. Virology 223, 245-250.
57. Janin, J. & Rodier, F. (1995). Protein-protein interaction at crystal contacts. Proteins 23, 580-587.
58. Cho, Y., Gorina, S., Jeffrey, P. & Pavletich, N.P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
59. Fusaki, N., Matsuda, S., Nishizumi, H., Umemori, H. & Yamamoto, T. (1996). Physical and functional interactions of protein tyrosine kinases, p59fyn and ZAP-70, in T cell signaling. J. Immunol. 156, 1369-1377.
60. Pedrava-Alva, G., Mérida, L.B., Burakoff, S.J. & Rosenstein, Y. (1996). CD43-specific activation of T cells induces association of CD43 to Fyn kinase. J. Biol. Chem. 271, 27564-27568.
61. Atkinson, E.A., et al., & Bleackley, R.C. (1 996). A physical interaction between the cell death protein Fas and tyrosine kinase p59. J. Biol. Chem. 271, 5968-5971.
62. Qian, D., et al., & Weiss, A. (1997). Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J. Exp. Med. 185, 1253-1259.
63. Moarefi, I., et al., & Miller, W.T. (1997). Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385, 650-653.
64. Sicheri, F., Moarefi, I. & Kuriyan, J. (1997). Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
65. Kabsch, W. (1993). Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 26, 795-800.
66. Collaborative Computing Project, No. 4. (1994). The CCP4 suite: programs for protein crystallography. Acta Cryst. D 50, 760-763.
67. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Cryst. A 50, 157-163.
68. Brünger, A.T. (1993). X-PLOR Version 3.1 Manual. Yale University, New Haven, CT, USA.
69. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1993). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. D 49, 148-157.
70. Laskowski, R., MacArthur, M., Moss, D. & Thornton, J. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 91-97.
71. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.
72. Meritt, E.A. & Murphy, M.E.P. (1994). Raster 3D version 2.0 - a program for photorealistic molecular graphics. Acta Cryst. D 50, 869-873.
73. Nicholls, A., Sharp, K.A. & Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.